nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Amantadine—ABCB1—kidney cancer	0.00728	1	CrCbGaD
Rimantadine—Fatigue—Erlotinib—kidney cancer	0.00229	0.00231	CcSEcCtD
Rimantadine—Anorexia—Sorafenib—kidney cancer	0.00228	0.0023	CcSEcCtD
Rimantadine—Feeling abnormal—Vinblastine—kidney cancer	0.00228	0.00229	CcSEcCtD
Rimantadine—Constipation—Erlotinib—kidney cancer	0.00227	0.00229	CcSEcCtD
Rimantadine—Feeling abnormal—Everolimus—kidney cancer	0.00227	0.00229	CcSEcCtD
Rimantadine—Shock—Sunitinib—kidney cancer	0.00226	0.00228	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vinblastine—kidney cancer	0.00226	0.00228	CcSEcCtD
Rimantadine—Gastrointestinal pain—Everolimus—kidney cancer	0.00225	0.00227	CcSEcCtD
Rimantadine—Dysphagia—Capecitabine—kidney cancer	0.00223	0.00225	CcSEcCtD
Rimantadine—Vomiting—Pazopanib—kidney cancer	0.00222	0.00223	CcSEcCtD
Rimantadine—Rash—Pazopanib—kidney cancer	0.0022	0.00222	CcSEcCtD
Rimantadine—Nausea—Temsirolimus—kidney cancer	0.0022	0.00221	CcSEcCtD
Rimantadine—Dermatitis—Pazopanib—kidney cancer	0.0022	0.00221	CcSEcCtD
Rimantadine—Bronchospasm—Capecitabine—kidney cancer	0.00219	0.00221	CcSEcCtD
Rimantadine—Anorexia—Sunitinib—kidney cancer	0.00219	0.00221	CcSEcCtD
Rimantadine—Agitation—Vincristine—kidney cancer	0.00219	0.00221	CcSEcCtD
Rimantadine—Abdominal pain—Vinblastine—kidney cancer	0.00219	0.0022	CcSEcCtD
Rimantadine—Headache—Pazopanib—kidney cancer	0.00218	0.0022	CcSEcCtD
Rimantadine—Abdominal pain—Everolimus—kidney cancer	0.00218	0.00219	CcSEcCtD
Rimantadine—Gastrointestinal pain—Erlotinib—kidney cancer	0.00217	0.00219	CcSEcCtD
Rimantadine—Sweating increased—Capecitabine—kidney cancer	0.00217	0.00219	CcSEcCtD
Rimantadine—Hypoaesthesia—Paclitaxel—kidney cancer	0.00216	0.00218	CcSEcCtD
Rimantadine—Oedema peripheral—Paclitaxel—kidney cancer	0.00214	0.00216	CcSEcCtD
Rimantadine—Dyspnoea—Sorafenib—kidney cancer	0.00213	0.00215	CcSEcCtD
Rimantadine—Dyspepsia—Sorafenib—kidney cancer	0.0021	0.00212	CcSEcCtD
Rimantadine—Abdominal pain—Erlotinib—kidney cancer	0.0021	0.00212	CcSEcCtD
Rimantadine—Insomnia—Sunitinib—kidney cancer	0.00208	0.0021	CcSEcCtD
Rimantadine—Decreased appetite—Sorafenib—kidney cancer	0.00208	0.00209	CcSEcCtD
Rimantadine—Anorexia—Dactinomycin—kidney cancer	0.00208	0.00209	CcSEcCtD
Rimantadine—Nausea—Pazopanib—kidney cancer	0.00207	0.00209	CcSEcCtD
Rimantadine—Convulsion—Vincristine—kidney cancer	0.00207	0.00208	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00206	0.00208	CcSEcCtD
Rimantadine—Fatigue—Sorafenib—kidney cancer	0.00206	0.00208	CcSEcCtD
Rimantadine—Hypertension—Vincristine—kidney cancer	0.00206	0.00207	CcSEcCtD
Rimantadine—Dyspnoea—Sunitinib—kidney cancer	0.00205	0.00207	CcSEcCtD
Rimantadine—Constipation—Sorafenib—kidney cancer	0.00204	0.00206	CcSEcCtD
Rimantadine—Tinnitus—Paclitaxel—kidney cancer	0.00203	0.00204	CcSEcCtD
Rimantadine—Dyspepsia—Sunitinib—kidney cancer	0.00202	0.00204	CcSEcCtD
Rimantadine—Decreased appetite—Sunitinib—kidney cancer	0.002	0.00201	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—kidney cancer	0.00199	0.002	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00199	0.002	CcSEcCtD
Rimantadine—Asthenia—Vinblastine—kidney cancer	0.00198	0.002	CcSEcCtD
Rimantadine—Fatigue—Sunitinib—kidney cancer	0.00198	0.002	CcSEcCtD
Rimantadine—Depression—Capecitabine—kidney cancer	0.00198	0.002	CcSEcCtD
Rimantadine—Asthenia—Everolimus—kidney cancer	0.00198	0.00199	CcSEcCtD
Rimantadine—Cough—Gemcitabine—kidney cancer	0.00197	0.00199	CcSEcCtD
Rimantadine—Constipation—Sunitinib—kidney cancer	0.00197	0.00198	CcSEcCtD
Rimantadine—Gastrointestinal pain—Sorafenib—kidney cancer	0.00195	0.00197	CcSEcCtD
Rimantadine—Hypertension—Gemcitabine—kidney cancer	0.00195	0.00197	CcSEcCtD
Rimantadine—Chills—Paclitaxel—kidney cancer	0.00195	0.00197	CcSEcCtD
Rimantadine—Stomatitis—Capecitabine—kidney cancer	0.00194	0.00195	CcSEcCtD
Rimantadine—Asthenia—Erlotinib—kidney cancer	0.00191	0.00192	CcSEcCtD
Rimantadine—Decreased appetite—Dactinomycin—kidney cancer	0.00189	0.00191	CcSEcCtD
Rimantadine—Diarrhoea—Vinblastine—kidney cancer	0.00189	0.00191	CcSEcCtD
Rimantadine—Abdominal pain—Sorafenib—kidney cancer	0.00189	0.0019	CcSEcCtD
Rimantadine—Diarrhoea—Everolimus—kidney cancer	0.00188	0.0019	CcSEcCtD
Rimantadine—Gastrointestinal pain—Sunitinib—kidney cancer	0.00188	0.00189	CcSEcCtD
Rimantadine—Hyperhidrosis—Vincristine—kidney cancer	0.00188	0.00189	CcSEcCtD
Rimantadine—Fatigue—Dactinomycin—kidney cancer	0.00188	0.00189	CcSEcCtD
Rimantadine—Tension—Paclitaxel—kidney cancer	0.00186	0.00187	CcSEcCtD
Rimantadine—Anorexia—Vincristine—kidney cancer	0.00185	0.00187	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—kidney cancer	0.00184	0.00186	CcSEcCtD
Rimantadine—Nervousness—Paclitaxel—kidney cancer	0.00184	0.00185	CcSEcCtD
Rimantadine—Dizziness—Vinblastine—kidney cancer	0.00183	0.00184	CcSEcCtD
Rimantadine—Dizziness—Everolimus—kidney cancer	0.00182	0.00183	CcSEcCtD
Rimantadine—Abdominal pain—Sunitinib—kidney cancer	0.00182	0.00183	CcSEcCtD
Rimantadine—Diarrhoea—Erlotinib—kidney cancer	0.00182	0.00183	CcSEcCtD
Rimantadine—Feeling abnormal—Dactinomycin—kidney cancer	0.00179	0.00181	CcSEcCtD
Rimantadine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00178	0.0018	CcSEcCtD
Rimantadine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00178	0.00179	CcSEcCtD
Rimantadine—Hypoaesthesia—Capecitabine—kidney cancer	0.00178	0.00179	CcSEcCtD
Rimantadine—Tremor—Paclitaxel—kidney cancer	0.00177	0.00179	CcSEcCtD
Rimantadine—Insomnia—Vincristine—kidney cancer	0.00176	0.00177	CcSEcCtD
Rimantadine—Anorexia—Gemcitabine—kidney cancer	0.00176	0.00177	CcSEcCtD
Rimantadine—Oedema peripheral—Capecitabine—kidney cancer	0.00176	0.00177	CcSEcCtD
Rimantadine—Vomiting—Vinblastine—kidney cancer	0.00176	0.00177	CcSEcCtD
Rimantadine—Dizziness—Erlotinib—kidney cancer	0.00176	0.00177	CcSEcCtD
Rimantadine—Vomiting—Everolimus—kidney cancer	0.00175	0.00176	CcSEcCtD
Rimantadine—Agitation—Paclitaxel—kidney cancer	0.00174	0.00175	CcSEcCtD
Rimantadine—Rash—Everolimus—kidney cancer	0.00174	0.00175	CcSEcCtD
Rimantadine—Dermatitis—Everolimus—kidney cancer	0.00173	0.00175	CcSEcCtD
Rimantadine—Headache—Vinblastine—kidney cancer	0.00173	0.00174	CcSEcCtD
Rimantadine—Headache—Everolimus—kidney cancer	0.00173	0.00174	CcSEcCtD
Rimantadine—Abdominal pain—Dactinomycin—kidney cancer	0.00172	0.00173	CcSEcCtD
Rimantadine—Asthenia—Sorafenib—kidney cancer	0.00171	0.00173	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—kidney cancer	0.0017	0.00172	CcSEcCtD
Rimantadine—Syncope—Paclitaxel—kidney cancer	0.0017	0.00171	CcSEcCtD
Rimantadine—Decreased appetite—Vincristine—kidney cancer	0.00169	0.0017	CcSEcCtD
Rimantadine—Vomiting—Erlotinib—kidney cancer	0.00169	0.0017	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vincristine—kidney cancer	0.00168	0.00169	CcSEcCtD
Rimantadine—Fatigue—Vincristine—kidney cancer	0.00168	0.00169	CcSEcCtD
Rimantadine—Rash—Erlotinib—kidney cancer	0.00168	0.00169	CcSEcCtD
Rimantadine—Dermatitis—Erlotinib—kidney cancer	0.00167	0.00169	CcSEcCtD
Rimantadine—Palpitations—Paclitaxel—kidney cancer	0.00167	0.00169	CcSEcCtD
Rimantadine—Insomnia—Gemcitabine—kidney cancer	0.00167	0.00168	CcSEcCtD
Rimantadine—Headache—Erlotinib—kidney cancer	0.00166	0.00168	CcSEcCtD
Rimantadine—Tinnitus—Capecitabine—kidney cancer	0.00166	0.00168	CcSEcCtD
Rimantadine—Loss of consciousness—Paclitaxel—kidney cancer	0.00166	0.00168	CcSEcCtD
Rimantadine—Constipation—Vincristine—kidney cancer	0.00166	0.00168	CcSEcCtD
Rimantadine—Cough—Paclitaxel—kidney cancer	0.00165	0.00166	CcSEcCtD
Rimantadine—Asthenia—Sunitinib—kidney cancer	0.00165	0.00166	CcSEcCtD
Rimantadine—Dyspnoea—Gemcitabine—kidney cancer	0.00165	0.00166	CcSEcCtD
Rimantadine—Nausea—Vinblastine—kidney cancer	0.00164	0.00165	CcSEcCtD
Rimantadine—Somnolence—Gemcitabine—kidney cancer	0.00164	0.00165	CcSEcCtD
Rimantadine—Convulsion—Paclitaxel—kidney cancer	0.00164	0.00165	CcSEcCtD
Rimantadine—Nausea—Everolimus—kidney cancer	0.00164	0.00165	CcSEcCtD
Rimantadine—Diarrhoea—Sorafenib—kidney cancer	0.00164	0.00165	CcSEcCtD
Rimantadine—Hypertension—Paclitaxel—kidney cancer	0.00163	0.00165	CcSEcCtD
Rimantadine—Anxiety—Paclitaxel—kidney cancer	0.00161	0.00162	CcSEcCtD
Rimantadine—Decreased appetite—Gemcitabine—kidney cancer	0.0016	0.00162	CcSEcCtD
Rimantadine—Chills—Capecitabine—kidney cancer	0.0016	0.00161	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00159	0.0016	CcSEcCtD
Rimantadine—Fatigue—Gemcitabine—kidney cancer	0.00159	0.0016	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vincristine—kidney cancer	0.00159	0.0016	CcSEcCtD
Rimantadine—Dizziness—Sorafenib—kidney cancer	0.00158	0.00159	CcSEcCtD
Rimantadine—Constipation—Gemcitabine—kidney cancer	0.00158	0.00159	CcSEcCtD
Rimantadine—Nausea—Erlotinib—kidney cancer	0.00158	0.00159	CcSEcCtD
Rimantadine—Dry mouth—Paclitaxel—kidney cancer	0.00158	0.00159	CcSEcCtD
Rimantadine—Diarrhoea—Sunitinib—kidney cancer	0.00157	0.00159	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—kidney cancer	0.00156	0.00158	CcSEcCtD
Rimantadine—Asthenia—Dactinomycin—kidney cancer	0.00156	0.00157	CcSEcCtD
Rimantadine—Confusional state—Paclitaxel—kidney cancer	0.00156	0.00157	CcSEcCtD
Rimantadine—Abdominal pain—Vincristine—kidney cancer	0.00154	0.00155	CcSEcCtD
Rimantadine—Dizziness—Sunitinib—kidney cancer	0.00152	0.00153	CcSEcCtD
Rimantadine—Feeling abnormal—Gemcitabine—kidney cancer	0.00152	0.00153	CcSEcCtD
Rimantadine—Shock—Paclitaxel—kidney cancer	0.00152	0.00153	CcSEcCtD
Rimantadine—Vomiting—Sorafenib—kidney cancer	0.00152	0.00153	CcSEcCtD
Rimantadine—Tachycardia—Paclitaxel—kidney cancer	0.00151	0.00152	CcSEcCtD
Rimantadine—Rash—Sorafenib—kidney cancer	0.00151	0.00152	CcSEcCtD
Rimantadine—Dermatitis—Sorafenib—kidney cancer	0.00151	0.00152	CcSEcCtD
Rimantadine—Headache—Sorafenib—kidney cancer	0.0015	0.00151	CcSEcCtD
Rimantadine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00149	0.0015	CcSEcCtD
Rimantadine—Diarrhoea—Dactinomycin—kidney cancer	0.00149	0.0015	CcSEcCtD
Rimantadine—Anorexia—Paclitaxel—kidney cancer	0.00147	0.00148	CcSEcCtD
Rimantadine—Vomiting—Sunitinib—kidney cancer	0.00146	0.00147	CcSEcCtD
Rimantadine—Tremor—Capecitabine—kidney cancer	0.00146	0.00147	CcSEcCtD
Rimantadine—Rash—Sunitinib—kidney cancer	0.00145	0.00146	CcSEcCtD
Rimantadine—Dermatitis—Sunitinib—kidney cancer	0.00145	0.00146	CcSEcCtD
Rimantadine—Headache—Sunitinib—kidney cancer	0.00144	0.00145	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—kidney cancer	0.00144	0.00145	CcSEcCtD
Rimantadine—Nausea—Sorafenib—kidney cancer	0.00142	0.00143	CcSEcCtD
Rimantadine—Insomnia—Paclitaxel—kidney cancer	0.0014	0.00141	CcSEcCtD
Rimantadine—Asthenia—Vincristine—kidney cancer	0.0014	0.00141	CcSEcCtD
Rimantadine—Syncope—Capecitabine—kidney cancer	0.00139	0.0014	CcSEcCtD
Rimantadine—Vomiting—Dactinomycin—kidney cancer	0.00138	0.00139	CcSEcCtD
Rimantadine—Dyspnoea—Paclitaxel—kidney cancer	0.00138	0.00139	CcSEcCtD
Rimantadine—Somnolence—Paclitaxel—kidney cancer	0.00137	0.00138	CcSEcCtD
Rimantadine—Palpitations—Capecitabine—kidney cancer	0.00137	0.00138	CcSEcCtD
Rimantadine—Rash—Dactinomycin—kidney cancer	0.00137	0.00138	CcSEcCtD
Rimantadine—Nausea—Sunitinib—kidney cancer	0.00137	0.00138	CcSEcCtD
Rimantadine—Loss of consciousness—Capecitabine—kidney cancer	0.00137	0.00138	CcSEcCtD
Rimantadine—Dyspepsia—Paclitaxel—kidney cancer	0.00136	0.00137	CcSEcCtD
Rimantadine—Cough—Capecitabine—kidney cancer	0.00136	0.00137	CcSEcCtD
Rimantadine—Decreased appetite—Paclitaxel—kidney cancer	0.00134	0.00135	CcSEcCtD
Rimantadine—Hypertension—Capecitabine—kidney cancer	0.00134	0.00135	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00133	0.00134	CcSEcCtD
Rimantadine—Fatigue—Paclitaxel—kidney cancer	0.00133	0.00134	CcSEcCtD
Rimantadine—Diarrhoea—Vincristine—kidney cancer	0.00133	0.00134	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—kidney cancer	0.00133	0.00134	CcSEcCtD
Rimantadine—Asthenia—Gemcitabine—kidney cancer	0.00132	0.00133	CcSEcCtD
Rimantadine—Constipation—Paclitaxel—kidney cancer	0.00132	0.00133	CcSEcCtD
Rimantadine—Anxiety—Capecitabine—kidney cancer	0.00132	0.00133	CcSEcCtD
Rimantadine—Dry mouth—Capecitabine—kidney cancer	0.00129	0.0013	CcSEcCtD
Rimantadine—Nausea—Dactinomycin—kidney cancer	0.00129	0.0013	CcSEcCtD
Rimantadine—Dizziness—Vincristine—kidney cancer	0.00129	0.0013	CcSEcCtD
Rimantadine—Confusional state—Capecitabine—kidney cancer	0.00128	0.00129	CcSEcCtD
Rimantadine—Feeling abnormal—Paclitaxel—kidney cancer	0.00127	0.00128	CcSEcCtD
Rimantadine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00126	0.00127	CcSEcCtD
Rimantadine—Diarrhoea—Gemcitabine—kidney cancer	0.00126	0.00127	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—kidney cancer	0.00125	0.00126	CcSEcCtD
Rimantadine—Shock—Capecitabine—kidney cancer	0.00125	0.00126	CcSEcCtD
Rimantadine—Tachycardia—Capecitabine—kidney cancer	0.00124	0.00125	CcSEcCtD
Rimantadine—Vomiting—Vincristine—kidney cancer	0.00124	0.00125	CcSEcCtD
Rimantadine—Rash—Vincristine—kidney cancer	0.00123	0.00124	CcSEcCtD
Rimantadine—Hyperhidrosis—Capecitabine—kidney cancer	0.00123	0.00123	CcSEcCtD
Rimantadine—Dermatitis—Vincristine—kidney cancer	0.00123	0.00123	CcSEcCtD
Rimantadine—Abdominal pain—Paclitaxel—kidney cancer	0.00122	0.00123	CcSEcCtD
Rimantadine—Headache—Vincristine—kidney cancer	0.00122	0.00123	CcSEcCtD
Rimantadine—Anorexia—Capecitabine—kidney cancer	0.00121	0.00122	CcSEcCtD
Rimantadine—Vomiting—Gemcitabine—kidney cancer	0.00117	0.00118	CcSEcCtD
Rimantadine—Rash—Gemcitabine—kidney cancer	0.00116	0.00117	CcSEcCtD
Rimantadine—Dermatitis—Gemcitabine—kidney cancer	0.00116	0.00117	CcSEcCtD
Rimantadine—Headache—Gemcitabine—kidney cancer	0.00116	0.00116	CcSEcCtD
Rimantadine—Nausea—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Rimantadine—Insomnia—Capecitabine—kidney cancer	0.00115	0.00116	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—kidney cancer	0.00114	0.00115	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—kidney cancer	0.00113	0.00114	CcSEcCtD
Rimantadine—Dyspnoea—Capecitabine—kidney cancer	0.00113	0.00114	CcSEcCtD
Rimantadine—Dyspepsia—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Rimantadine—Asthenia—Paclitaxel—kidney cancer	0.00111	0.00112	CcSEcCtD
Rimantadine—Decreased appetite—Capecitabine—kidney cancer	0.0011	0.00111	CcSEcCtD
Rimantadine—Nausea—Gemcitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00109	0.0011	CcSEcCtD
Rimantadine—Fatigue—Capecitabine—kidney cancer	0.00109	0.0011	CcSEcCtD
Rimantadine—Constipation—Capecitabine—kidney cancer	0.00108	0.00109	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—kidney cancer	0.00107	0.00108	CcSEcCtD
Rimantadine—Diarrhoea—Paclitaxel—kidney cancer	0.00106	0.00106	CcSEcCtD
Rimantadine—Feeling abnormal—Capecitabine—kidney cancer	0.00104	0.00105	CcSEcCtD
Rimantadine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Rimantadine—Chills—Doxorubicin—kidney cancer	0.00103	0.00104	CcSEcCtD
Rimantadine—Dizziness—Paclitaxel—kidney cancer	0.00102	0.00103	CcSEcCtD
Rimantadine—Abdominal pain—Capecitabine—kidney cancer	0.001	0.00101	CcSEcCtD
Rimantadine—Tension—Doxorubicin—kidney cancer	0.000983	0.00099	CcSEcCtD
Rimantadine—Vomiting—Paclitaxel—kidney cancer	0.000982	0.00099	CcSEcCtD
Rimantadine—Rash—Paclitaxel—kidney cancer	0.000974	0.000981	CcSEcCtD
Rimantadine—Dermatitis—Paclitaxel—kidney cancer	0.000973	0.00098	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—kidney cancer	0.000973	0.00098	CcSEcCtD
Rimantadine—Headache—Paclitaxel—kidney cancer	0.000968	0.000975	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—kidney cancer	0.00092	0.000927	CcSEcCtD
Rimantadine—Nausea—Paclitaxel—kidney cancer	0.000918	0.000925	CcSEcCtD
Rimantadine—Asthenia—Capecitabine—kidney cancer	0.00091	0.000916	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—kidney cancer	0.000898	0.000905	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—kidney cancer	0.000885	0.000892	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—kidney cancer	0.00088	0.000887	CcSEcCtD
Rimantadine—Cough—Doxorubicin—kidney cancer	0.000874	0.00088	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—kidney cancer	0.000868	0.000874	CcSEcCtD
Rimantadine—Diarrhoea—Capecitabine—kidney cancer	0.000868	0.000874	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—kidney cancer	0.000865	0.000871	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—kidney cancer	0.00085	0.000856	CcSEcCtD
Rimantadine—Dizziness—Capecitabine—kidney cancer	0.000838	0.000845	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—kidney cancer	0.000834	0.00084	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—kidney cancer	0.000824	0.00083	CcSEcCtD
Rimantadine—Vomiting—Capecitabine—kidney cancer	0.000806	0.000812	CcSEcCtD
Rimantadine—Shock—Doxorubicin—kidney cancer	0.000804	0.00081	CcSEcCtD
Rimantadine—Rash—Capecitabine—kidney cancer	0.000799	0.000805	CcSEcCtD
Rimantadine—Dermatitis—Capecitabine—kidney cancer	0.000799	0.000805	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—kidney cancer	0.000798	0.000804	CcSEcCtD
Rimantadine—Headache—Capecitabine—kidney cancer	0.000794	0.0008	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—kidney cancer	0.00079	0.000796	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—kidney cancer	0.000779	0.000785	CcSEcCtD
Rimantadine—Nausea—Capecitabine—kidney cancer	0.000753	0.000759	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—kidney cancer	0.000739	0.000745	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—kidney cancer	0.000729	0.000734	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—kidney cancer	0.000727	0.000732	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—kidney cancer	0.000719	0.000725	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—kidney cancer	0.000711	0.000716	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000706	0.000711	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—kidney cancer	0.000705	0.00071	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—kidney cancer	0.000699	0.000704	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—kidney cancer	0.000674	0.000678	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000668	0.000673	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—kidney cancer	0.000646	0.000651	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—kidney cancer	0.000586	0.000591	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—kidney cancer	0.000559	0.000563	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—kidney cancer	0.00054	0.000544	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—kidney cancer	0.00052	0.000523	CcSEcCtD
Rimantadine—Rash—Doxorubicin—kidney cancer	0.000515	0.000519	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—kidney cancer	0.000515	0.000519	CcSEcCtD
Rimantadine—Headache—Doxorubicin—kidney cancer	0.000512	0.000516	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—kidney cancer	0.000485	0.000489	CcSEcCtD
